Ultra Sound Guided Genicular Nerves Cooled Radiofrequency Ablation in Total Knee Replacement Surgeries
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: abdallah soudi, M.D.
- Phone Number: +201111228925
- Email: Dr.soudi2014@med.asu.edu.eg
Study Locations
-
-
-
Cairo, Egypt, 02
- Faculty of medicine ain shams university
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:• Undergoing a scheduled unilateral total knee replacement surgery
-
Exclusion Criteria:
• Allergy to any of the drugs used in the study
- Alcohol or drug abuse
- Psychiatric disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: lumber epidural anesthesia
Patients will receive epidural anesthesia intra operative
|
Patients will receive epidural anesthesia intra operative and epidural analgesia post-operative
|
|
Experimental: lumber Epidural and unilateral genicular nerve ablation:
Patient will receive lumber epidural anesthesia and unilateral genicular nerve cooled radio frequency ablation pre-operative
|
Patients will receive epidural anesthesia intra operative and epidural analgesia post-operative
unilateral genicular nerve cooled radio frequency ablation pre-operative
|
|
Experimental: Epidural and bilateral genicular nerve ablation
Patient will receive lumber epidural anesthesia and bilateral genicular nerve cooled radio frequency ablation pre-operative
|
Patients will receive epidural anesthesia intra operative and epidural analgesia post-operative
bilateral genicular nerve cooled radio frequency ablation pre-operative
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
o Epidural rescue doses
Time Frame: 1st 48 hours
|
rescue doses reflects degree of pain control
|
1st 48 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
WOMAC score
Time Frame: baseline preoperative, and the at 2, 6 and 12 weeks postoperative
|
assessment of the functional state of the patient and degree of pain and limitation of movement
|
baseline preoperative, and the at 2, 6 and 12 weeks postoperative
|
|
Knee range of motion
Time Frame: Assessed weekly for 3 weeks postoperatively (Weeks 1, 2, and 3)
|
Time to achieve full knee range of motion will be assessed by measuring active knee flexion and extension in degrees (°) using a universal goniometer during weekly postoperative assessments.
The outcome will be reported as the number of days or weeks required to achieve full range of motion, as defined in the study protocol.
|
Assessed weekly for 3 weeks postoperatively (Weeks 1, 2, and 3)
|
|
Postoperative inflammatory signs assessed by clinical examination
Time Frame: Assessed weekly for 3 weeks postoperatively (Weeks 1, 2, and 3).
|
Postoperative inflammatory signs, including redness (erythema), local warmth, and swelling around the operated knee, will be assessed by clinical examination.
Each sign will be recorded as present or absent.
The outcome will be reported as the number of participants with each inflammatory sign at each assessment.
|
Assessed weekly for 3 weeks postoperatively (Weeks 1, 2, and 3).
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- FMASU R221/2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.